We have been infored that BioMarin has named it's gene therapy prodict. It was named Valrox but the new commercial name is Roctavian. We...

All information below was researched and written by Jesse John Francis Clark. This is Dr. Robert Sidonio, Jr currently hailing out of...

As you might already know, we have exposed NHF and its chapters for receiving fraudulent Payroll Protection Program loans. We wanted to...

As you might already know, we are exposing everything that is wrong with the bleeding disorders community. Hemophilia of Georgia has an...

Well, well, well, would you look at this! The National Hemophilia Foundation fraudulently applied for a Payroll Protection Program loan...

Genentech just released the quarterly Hemlibra death report. There are now 44 "reported" deaths. That number is up by 10 since last...

Genentech released the quarterly fatalities report for Emicizumab (Hemlibra) and there are now 34 reported deaths. This makes it the most...

The Cure 4 The Kids Foundation based in Las Vegas, Nevada lost its funding due to misappropriating federal funds. Annette Logan-Parker...

Well, like clockwork, Genentech has released the quarterly fatalities report for Hemlibra.(Emicizumab) A few weeks ago, we published a...

Just as gene therapy finally seems to be living up to its promise, a study has revived a lingering worry about the viral vessel that many...

Well, we are now in 2020. Last year was kind of rocky for the bleeding disorder community. There was a lot of not-so-good news that we...

On November 7, 2019, the New England Journal of Medicine published a letter to the Editor from Louis M. Aledort, M.D. from the Icahn...

Sanofi SA’s Genzyme unit cannot block a former employee from joining BioMarin Pharmaceutical Inc, where he would help launch a gene...

Well, Genentech just released their quarterly fatalities report on Emicizumab (Hemlibra) and we are now up to 17. This is 4 more than...

Tremeau Pharmaceuticals, a private Massachusetts company, is developing a generic version of Vioxx as a treatment for severe joint pain...

Ah, there is no shortage of news these days with these pharma companies. It’s a great time to have a bleeding disorder news website. CSL...

HemoAware's President and CEO, Jesse John Francis Clark was interviewed by MDedge for an article on Genentech's translucent particle...

Cambridge, Massachusetts-based bluebird bio and Bagsvaerd, Denmark-based Novo Nordisk announced they have agreed to collaborate to...

Today, Genentech released a statement (see below) regarding particulate matter found in Emicizumab. (HEMLIBRA) They noticed the matter...

Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into an expanded agreement with Sanofi to exercise early opt-in for the...